Bringing Next-Gen Intelligence to Clear Aligners
Laon Ortho is meticulously crafted for orthodontic professionals who invest significant time and expertise in treatment planning. Utilizing advanced technology, we automate routine tasks, enabling swift and precise treatment planning by analyzing comprehensive lateral X-ray, 3D scan data, and CBCT.
Accelerate your journey
from inspiration to building process.
Discover the future of clear aligner at Webinar 2024, where ideas become solutions.
Webinar 2024
Bringing Next-Gen Intelligence to Clear Aligners
Laon Ortho
See what's new!
Resources & Blog
Discover the future of clear aligner at Webinar 2024, where ideas become solutions.
Webinar 2024
Bringing Next-Gen Intelligence to Clear Aligners
Laon Ortho
News & Events
June 1. 2025
Innovation in Action: Laonmedi at SIDEX 2025!
Laonmedi showcased the latest features of its clear aligner software, 'Laon Ortho', at SIDEX 2025 from May 30 to June 1. Key highlights included 'One Click Setup', 'Timeline-based Precision Treatment', 'Cloud-based Data Management', and 'Real-time Diagnostics and Appliance Fabrication'. Visitors from around the world experienced Laonmedi's advanced capabilities in 'Auto diagnosis', '3D visualization', and 'In-clinic Aligner Production', drawing strong interest and praise for its practical dental solutions. SIDEX 2025 served as a milestone for expanding global partnerships and strengthening our market leadership. Laonmedi remains committed to making orthodontic treatment easier and more precise through continuous innovation.
April 29. 2025
Laonmedi Receives FDA Clearance for Dental Clear Aligner 'Laon Ortho'
Laonmedi's dental clear aligner software, 'Laon Ortho', has received clearance from the U.S. Food and Drug Administration (FDA), accelerating the company's expansion into the global market. Laon Ortho is a dental clear aligner software that uses CBCT (Cone Beam CT) data to automatically segment teeth—including roots—from scanned dental images and visualize them in 3D. The newly FDA-cleared features are expected to improve both the efficiency and precision of dental treatments.
January 15. 2025
Laonmedi Raises $3.51 million, Reaching $21.74 million Valuation!
Laonmedi has successfully raised a total of ₩4.85 billion (approx. $3.5 million) in funding from major institutional investors including K2 Investment Partners and Industrial Bank of Korea (IBK) between late 2024 and early 2025, bringing its company valuation to approximately ₩30 billion (approx. $22 million). This investment was made through a third-party allocation of new shares. The capital secured will be primarily used to advance Laonmedi's dental software technologies, accelerate global market expansion, and strengthen R&D capabilities. With this funding, Laonmedi plans to further enhance its competitiveness in overseas markets such as the U.S. and Europe, and actively prepare for a future initial public offering (IPO).